Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT06514677
Recruiting Not applicable

Non-Surgical Treatment of Peri-Implantitis With Ultrasonic Carbon Tip

NCT06514677 · tracked via the Priya Life Science Turkey tracker
Sponsor
Kutahya Health Sciences University
Phase
Not applicable
Started
2023-12-01
Last updated
2025-03-12

Condition(s) studied

Peri-ImplantitisAlveolar Bone Loss

Investigational drug(s) / intervention(s)

Ultrasonic Carbon TipTitanium Curette

Ultrasonic Carbon Tip: Using Ultrasonic Carbon Tip for Non-surgical Peri-implantitis Treatment

Titanium Curette: Using Titanium Curettes for for Non-surgical Peri-implantitis Treatment

Study summary

As the frequency of dental implants increases, the incidence of complications and peri-implant diseases also increases. Early diagnosis and treatment of the disease is important to prevent consequences up to implant loss. Non-surgical treatment is the recommended treatment in the first stage due to its shorter duration and low morbidity rate. Non-surgical treatment of peri-implantitis provides clinical improvements such as reduced bleeding on probing (20-50%) and, in some cases, reduced pocket depth (≤ 1 mm). This study aims to clinically and radiographically compare two different mechanical treatments in patients with mild and moderate peri-implantitis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
99 Years
Healthy volunteers
Accepted
Inclusion criteria: 1. Adult patients (≥18 years old) 2. Systemically healthy (ASA class 1 and ASA class 2) 3. Full-mouth plaque scores ≤20% 4. Implant had been in function for more than 6 months 5. Absence of plaque around the implant 6. Consent to complete all follow-up visits Exclusion criteria: 1. Mobile implant 2. Overhanging restorations that prevent access to the implant for clinical measurements 3. Unresolvable technical complications that can cause peri-implantitis 4. Presence of active periodontal disease 5. Implants with a history of peri-implantitis treated using graft materials 6. Use of drugs that cause gingival hyperplasia 7. Systemic antibiotic use in the last 3 months 8. Acute and chronic medical conditions that prevent the patient from participating in the study 9. Presence of uncontrolled severe peri-implantitis from neighbouring implants 10. History of radiotherapy in the head and neck region 11. Receiving acute chemotherapy 12. Current corticosteroid therapy

Primary outcome measure(s)

  • Periodontal depth decrease — Baseline to 12th month
    Periodontal pocket depth (PD) decreasing baseline to 12th month

Trial sites (1)

FacilityCityRegionStatus
Kütahya Health Sciences University Faculty of Dentistry, Department of Periodontology Kütahya Turkey (Türkiye) Recruiting

More Kutahya Health Sciences University trials in Turkey

Nurse-Led Caregiver Support Program in Home Palliative Care Recruiting
Evaluation of Hydrogel Application in the Treatment of Periodontitis and Peri-implantitis Active, not recruiting
VALIDITY AND RELIABILITY OF THE TURKISH VERSION OF THE SEX PAIN QUESTIONNAIRE Enrolling by invitation
Effects of Neurodynamic and Carpal Bone Mobilization in Mild-to-Moderate Carpal Tunnel Syndrome Starting soon
Assessment of Early Healing Period of Dental Implants Active, not recruiting

Other trials for the same condition

Reconstructive Treatment of Peri-implantitis With Combined Defects Recruiting
Evaluation of the Effectiveness of Odontogenic Grafts Obtained From Human Teeth on Bone Formation Enrolling by invitation
Comparison of Dental Implants with Different Surface Properties Enrolling by invitation
Odontogenic Graft Obtained From Human Tooth and Low Level Laser Therapy Enrolling by invitation
Electrolytic Surface Decontamination in the Surgical Treatment of Peri-implantitis: A Randomized Clinical Trial Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06514677 on ClinicalTrials.gov ↗ ← All trials in Turkey